Common Contracts
3 similar Security Agreement contracts by Avinger Inc, Durata Therapeutics, Inc.
SECURITY AGREEMENT DATED AS OF APRIL 18, 2013 BY AVINGER, INC. AS GRANTOR, IN FAVOR OF PDL BIOPHARMA, INC., AS COLLATERAL AGENTSecurity Agreement • December 30th, 2014 • Avinger Inc • Surgical & medical instruments & apparatus • New York
SECURITY AGREEMENT, dated as of April 18, 2013, by AVINGER, INC., a Delaware corporation (together with any other entity that may become a party hereto as a grantor as provided herein, each a “Grantor” and collectively, jointly and severally, the “Grantors”) in favor of PDL BIOPHARMA, INC., as Collateral Agent (in such capacity, the “Agent”) under the Credit Agreement, dated as of April 18, 2013 (as amended, supplemented or otherwise modified from time to time, the “Credit Agreement”) among the Grantor, as borrower (in such capacity, the “Borrower”), and the Agent, as lender (in such capacity, the “Lender”) and agent.
SECURITY AGREEMENT DATED AS OF APRIL 18, 2013 BY AVINGER, INC. AS GRANTOR, IN FAVOR OF PDL BIOPHARMA, INC., AS COLLATERAL AGENTSecurity Agreement • November 6th, 2014 • Avinger Inc • Surgical & medical instruments & apparatus • New York
SECURITY AGREEMENT, dated as of April 18, 2013, by AVINGER, INC., a Delaware corporation (together with any other entity that may become a party hereto as a grantor as provided herein, each a “Grantor” and collectively, jointly and severally, the “Grantors”) in favor of PDL BIOPHARMA, INC., as Collateral Agent (in such capacity, the “Agent”) under the Credit Agreement, dated as of April 18, 2013 (as amended, supplemented or otherwise modified from time to time, the “Credit Agreement”) among the Grantor, as borrower (in such capacity, the “Borrower”), and the Agent, as lender (in such capacity, the “Lender”) and agent.
SECURITY AGREEMENT DATED AS OF OCTOBER 31, 2013 BY AND AMONG DURATA THERAPEUTICS HOLDING C.V., DURATA THERAPEUTICS INTERNATIONAL B.V., DURATA THERAPEUTICS, INC., AND CERTAIN SUBSIDIARIES OF DURATA THERAPEUTICS, INC. PARTY HERETO AS GRANTORS, IN FAVOR...Security Agreement • March 14th, 2014 • Durata Therapeutics, Inc. • Pharmaceutical preparations • New York
SECURITY AGREEMENT (the “Agreement”), dated as of October 31, 2013, by DURATA THERAPEUTICS HOLDING C.V., a limited partnership organized under the laws of the Netherlands (“Durata C.V.”), DURATA THERAPEUTICS INTERNATIONAL B.V., a private company with limited liability incorporated under the laws of the Netherlands having its official seat in Amsterdam, the Netherlands, and which is registered with the Dutch trade register under number 55527221 (“Durata B.V.”), DURATA THERAPEUTICS, INC., a Delaware corporation (“Parent”), Durata Therapeutics U.S. Limited, a Delaware corporation (“Durata U.S.”) and certain other subsidiaries of Parent that are party hereto (Durata U.S. together with such other subsidiaries, the “Subsidiaries” and together with Durata C.V., Durata B.V., Parent, and any other entity that may become a party hereto as a grantor as provided herein, each a “Grantor” and collectively, jointly and severally, the “Grantors”), in favor of PDL BIOPHARMA, INC., as Collateral Agent (
